Your browser doesn't support javascript.
loading
Preclinical activity of a novel multi-axis inhibitor in aggressive and indolent B-cell malignancies.
Smith, Audrey L; Pal, Dhananjaya; Martinez-Rico, Rolando; Eiken, Alexandria P; Durden, Donald L; Kutateladze, Tatiana G; El-Gamal, Dalia.
Afiliação
  • Smith AL; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA.
  • Pal D; College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, USA.
  • Martinez-Rico R; Division of Hematology and Oncology, Department of Pediatrics, Moores Cancer Center, University of California San Diego, CA, USA.
  • Eiken AP; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA.
  • Durden DL; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA.
  • Kutateladze TG; College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, USA.
  • El-Gamal D; Division of Hematology and Oncology, Department of Pediatrics, Moores Cancer Center, University of California San Diego, CA, USA.
Leuk Lymphoma ; 64(14): 2333-2337, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37706519
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Linfoma de Célula do Manto Limite: Humans Idioma: En Revista: Leuk Lymphoma Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Linfoma de Célula do Manto Limite: Humans Idioma: En Revista: Leuk Lymphoma Ano de publicação: 2023 Tipo de documento: Article